Recruitment

Recruitment Status
Terminated
Estimated Enrollment
25

Inclusion Criteria

Patient presenting at least one of these symptoms indicative of proximal DVT: leg pain, tenderness (discomfort through palpation), leg swelling and /or edema,
The study population tested will be recruited from ambulatory outpatients (presenting at the emergency unit or outpatient clinic) suspected of having DVT.
Patient has confirmed proximal DVT by imaging
...
Patient presenting at least one of these symptoms indicative of proximal DVT: leg pain, tenderness (discomfort through palpation), leg swelling and /or edema,
The study population tested will be recruited from ambulatory outpatients (presenting at the emergency unit or outpatient clinic) suspected of having DVT.
Patient has confirmed proximal DVT by imaging
Low or moderate Wells score
Patient is < 80 years old.
Patient provides written informed consent to participate in the sample collection

Exclusion Criteria

Ongoing therapeutic anticoagulants (curative and preventive treatment) starting twenty four (24) hours or more before the blood drawing for D-dimer testing
Disseminated malignancies and active cancer (active cancer defined as: cancer for which therapeutic or palliative treatment is either ongoing at the time of enrolment or has stopped less than six (6) months before enrolment),
Sickle cell disease,
...
Ongoing therapeutic anticoagulants (curative and preventive treatment) starting twenty four (24) hours or more before the blood drawing for D-dimer testing
Disseminated malignancies and active cancer (active cancer defined as: cancer for which therapeutic or palliative treatment is either ongoing at the time of enrolment or has stopped less than six (6) months before enrolment),
Sickle cell disease,
Deep hematoma diagnosed by imaging techniques within the previous one (1) month,
Known liver cirrhosis,
Sepsis, severe infections, pneumonia within the previous 1 month,
Fibrinolytic therapy within the previous seven (7) days,
Bone fracture or surgery (with general anesthesia longer than thirty (30) minutes) within the previous one (1) month,
Atherosclerotic vascular disease thrombosis within the previous 1month (e.g. myocardial infarction, stroke, coronary syndrome, peripheral artery disease stage III or IV),
Pregnancy or post-partum within the previous 1 month,
Patients presenting with a suspect thrombotic event related to catheter implantation

Summary

Conditions
Deep Venous Thrombosis
Type
Observational
Design
  • Observational Model: Case-Only
  • Time Perspective: Prospective

Participation Requirements

Age
Younger than 80 years
Gender
Both males and females

Inclusion Criteria

Patient presenting at least one of these symptoms indicative of proximal DVT: leg pain, tenderness (discomfort through palpation), leg swelling and /or edema,
The study population tested will be recruited from ambulatory outpatients (presenting at the emergency unit or outpatient clinic) suspected of having DVT.
Patient has confirmed proximal DVT by imaging
...
Patient presenting at least one of these symptoms indicative of proximal DVT: leg pain, tenderness (discomfort through palpation), leg swelling and /or edema,
The study population tested will be recruited from ambulatory outpatients (presenting at the emergency unit or outpatient clinic) suspected of having DVT.
Patient has confirmed proximal DVT by imaging
Low or moderate Wells score
Patient is < 80 years old.
Patient provides written informed consent to participate in the sample collection

Exclusion Criteria

Ongoing therapeutic anticoagulants (curative and preventive treatment) starting twenty four (24) hours or more before the blood drawing for D-dimer testing
Disseminated malignancies and active cancer (active cancer defined as: cancer for which therapeutic or palliative treatment is either ongoing at the time of enrolment or has stopped less than six (6) months before enrolment),
Sickle cell disease,
...
Ongoing therapeutic anticoagulants (curative and preventive treatment) starting twenty four (24) hours or more before the blood drawing for D-dimer testing
Disseminated malignancies and active cancer (active cancer defined as: cancer for which therapeutic or palliative treatment is either ongoing at the time of enrolment or has stopped less than six (6) months before enrolment),
Sickle cell disease,
Deep hematoma diagnosed by imaging techniques within the previous one (1) month,
Known liver cirrhosis,
Sepsis, severe infections, pneumonia within the previous 1 month,
Fibrinolytic therapy within the previous seven (7) days,
Bone fracture or surgery (with general anesthesia longer than thirty (30) minutes) within the previous one (1) month,
Atherosclerotic vascular disease thrombosis within the previous 1month (e.g. myocardial infarction, stroke, coronary syndrome, peripheral artery disease stage III or IV),
Pregnancy or post-partum within the previous 1 month,
Patients presenting with a suspect thrombotic event related to catheter implantation

Tracking Information

NCT #
NCT02078154
Collaborators
Not Provided
Investigators
  • Principal Investigator: Suman Wasan Rathbun, MD University of Oklahoma Health Sciences
  • Suman Wasan Rathbun, MD University of Oklahoma Health Sciences